CA2103351A1 - Method of treatment using steroid mouthwash - Google Patents

Method of treatment using steroid mouthwash

Info

Publication number
CA2103351A1
CA2103351A1 CA 2103351 CA2103351A CA2103351A1 CA 2103351 A1 CA2103351 A1 CA 2103351A1 CA 2103351 CA2103351 CA 2103351 CA 2103351 A CA2103351 A CA 2103351A CA 2103351 A1 CA2103351 A1 CA 2103351A1
Authority
CA
Canada
Prior art keywords
application
gels
mouthwash
inflammatory
ointments
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA 2103351
Other languages
French (fr)
Other versions
CA2103351C (en
Inventor
Drore Eisen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2103351A1 publication Critical patent/CA2103351A1/en
Application granted granted Critical
Publication of CA2103351C publication Critical patent/CA2103351C/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/63—Steroids; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/494—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
    • A61K8/4946—Imidazoles or their condensed derivatives, e.g. benzimidazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/60—Sugars; Derivatives thereof
    • A61K8/602—Glycosides, e.g. rutin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Birds (AREA)
  • Molecular Biology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Medicinal Preparation (AREA)

Abstract

The object of the present invention is to provide a means of treating patients suffering from inflammatory conditions of the mouth using aqueous anti-inflammatory steroids in solutions that can be swished and expectorated as a mouthwash. Such therapy would allow direct contact of the medication with the diseased mucous membranes and would contact areas of the oral cavity that would not usually be reached with application of creams, gels, or ointments. Swishing for three to five minutes, then expectorating the aqueous anti-inflammatory-containing, results in maintenance of contact of the active agents with the oral cavity surfaces for a longer time than would application of gels containing those agents. The mode of application is simple and is not repugnant to the patient as is the application of creams, gels or ointments.
CA 2103351 1991-04-11 1992-04-10 Method of treatment using steroid mouthwash Expired - Fee Related CA2103351C (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US68338091A 1991-04-11 1991-04-11
US683,380 1991-04-11
US80264691A 1991-12-09 1991-12-09
US802,646 1991-12-09

Publications (2)

Publication Number Publication Date
CA2103351A1 true CA2103351A1 (en) 1992-10-29
CA2103351C CA2103351C (en) 2000-01-25

Family

ID=27103091

Family Applications (1)

Application Number Title Priority Date Filing Date
CA 2103351 Expired - Fee Related CA2103351C (en) 1991-04-11 1992-04-10 Method of treatment using steroid mouthwash

Country Status (4)

Country Link
EP (1) EP0579760A4 (en)
AU (1) AU1779192A (en)
CA (1) CA2103351C (en)
WO (1) WO1992018133A1 (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005072690A1 (en) * 2004-02-02 2005-08-11 Bernard Charles Sherman Antimicrobial oral rinse solid composition
WO2009043134A1 (en) * 2007-10-03 2009-04-09 Myrex Pharmaceuticals Inc. Mouthwash and method of using same for the treatment of mucositis or stomatitis

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69401336T2 (en) * 1993-01-21 1997-04-24 Janssen Pharmaceutica Nv TOPICAL KETOCONAZOLE MEDICINAL PRODUCT
US5993787A (en) * 1996-09-13 1999-11-30 Johnson & Johnson Consumer Products, Inc. Composition base for topical therapeutic and cosmetic preparations
EP1567113A4 (en) * 2002-10-24 2006-11-08 G & R Pharmaceuticals Llc Antifungal formulations
DE202016100357U1 (en) * 2016-01-27 2016-03-09 Peter Sommer Pharmaceutical preparation and use thereof in viral inflammatory diseases of the upper respiratory tract

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005072690A1 (en) * 2004-02-02 2005-08-11 Bernard Charles Sherman Antimicrobial oral rinse solid composition
WO2009043134A1 (en) * 2007-10-03 2009-04-09 Myrex Pharmaceuticals Inc. Mouthwash and method of using same for the treatment of mucositis or stomatitis

Also Published As

Publication number Publication date
WO1992018133A1 (en) 1992-10-29
CA2103351C (en) 2000-01-25
EP0579760A4 (en) 1995-07-05
EP0579760A1 (en) 1994-01-26
AU1779192A (en) 1992-11-17

Similar Documents

Publication Publication Date Title
AU598020B2 (en) Cosmetic composition
AU4342497A (en) Mouthwash comprising calcium and phosphate ions in supersaturated solution
DE68903442T2 (en) SOLID AND POROUS UNIT, CONTAINING MICROPARTICLES AND / OR NANOPARTICLES, AND METHOD FOR THE PRODUCTION THEREOF.
HRP920632A2 (en) Oral composition for the treatment of inflammatory l deseases
EP0147261A3 (en) Medicine and medicinal composition for the treatment and the prevention of skin affections involving an inflammation process
IE893840L (en) Use of acetyl d-carnitines for treating glaucoma
Ainamo et al. Prevention of plaque growth with chewing gum containing chlorhexidine acetate
WO1998035658A3 (en) The use of 2,3-dimethoxy-5-methyl-6-decaprenyl-1,4-benzoquinone
IT1204901B (en) COMPOSITIONS CONTAINING USNIC ACID OR ITS DERIVATIVES SUITABLE FOR USE IN THE TREATMENT OF TOOTH DECAY
TR199701294T1 (en) Composition consisting of amoxicillin and clavulanic acid.
IE893444L (en) Method for the treatment of periodontal disease
ATE192646T1 (en) USE OF A MIXTURE OF SUBSTANCES CONTAINING ALPHA HYDROXY ORGANIC ACID FOR THE PRODUCTION OF A MEDICINAL PRODUCT FOR THE TREATMENT OF MINOR ORAL ULCERS
DE69424777T2 (en) 3,4-DIARYLCHROMANE FOR TREATING DERMATITIS
CA2103351A1 (en) Method of treatment using steroid mouthwash
IL118218A (en) Pharmaceutical compositions containing sarcodictyins
EP0357646A4 (en) Treatment of aged skin with oral 13-cis-retinoic acid
CA2077693A1 (en) Use of ketorolac for treatment of periodontal disease
Wantke et al. Topical podophyllotoxin in psoriasis vulgaris
CA2259270A1 (en) Pharmaceutical preparation containing nimesulide for oral administration
FR2612774B1 (en) COSMETIC AND PHARMACEUTICAL COMPOSITIONS USED TO TREAT THE PROCESS OF ANDROGENOGENETIC ALOPECIA, CONTAINING AZELAIC ACID
AU3992897A (en) Use of sulbutiamine to obtain pharmaceutical compositions useful in the treatment of certain psychomotor and psycho-intellectual disorders
AU6133386A (en) Composition for preparing a medicament for topical treatment of paradentium diseases
GEP20012377B (en) Use of Trophoblastic Beta-1 Glycoprotein for Treating Auto-Immune Diseases and Method of Treatment These Diseases
SU1263246A1 (en) Method of treatment of acute stomatitis
AU3802289A (en) Treatment of periodontoclasia with retinoic acid

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed